UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 617

Sortiert nach

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

BMC cancer, 2014-10, Vol.14 (1), p.748-748, Article 748

2014

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the effect of information integration in displays for ICU nurses on situation awareness and task completion time: A prospective randomized controlled study

International journal of medical informatics (Shannon, Ireland), 2013-08, Vol.82 (8), p.665-675

2013

Link zum Volltext

Verfügbarkeit prüfen

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

Cancer Immunology, Immunotherapy, 2019-05, Vol.68 (5), p.799-812

2019

Link zum Volltext

Verfügbarkeit prüfen

RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial

Vaccine, 2019-03, Vol.37 (13), p.1819-1826

2019

Link zum Volltext

Verfügbarkeit prüfen

A novel, disruptive vaccination technology: Self-adjuvanted RNActive® vaccines

Human vaccines & immunotherapeutics, 2013-10, Vol.9 (10), p.2263-2276

2013

Link zum Volltext

Verfügbarkeit prüfen

A large multicentre, randomized, double‐blind, cross‐over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US‐ and EU‐reference biologics

British journal of clinical pharmacology, 2020-06, Vol.86 (6), p.1139-1149

2020

Link zum Volltext

Verfügbarkeit prüfen

Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people

Immunity & ageing, 2008-07, Vol.5 (1), p.6-6, Article 6

2008

Link zum Volltext

Verfügbarkeit prüfen

Intensive care unit nurses' information needs and recommendations for integrated displays to improve nurses' situation awareness

Journal of the American Medical Informatics Association : JAMIA, 2012-07, Vol.19 (4), p.583-590

2012

Link zum Volltext

Verfügbarkeit prüfen

Analysis of stem-cell-like properties of human CD161++IL-18Rα+ memory CD8+ T cells

International immunology, 2012-10, Vol.24 (10), p.625-636

2012

Link zum Volltext

Verfügbarkeit prüfen

Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity

Vaccines (Basel), 2024-04, Vol.12 (4), p.388

2024

Link zum Volltext

Verfügbarkeit prüfen

A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant

Vaccines (Basel), 2022-03, Vol.10 (4), p.508

2022

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas

Cancer research (Chicago, Ill.), 2009-11, Vol.69 (21), p.8412-8419

2009

Link zum Volltext

Verfügbarkeit prüfen

The perfectly motivated nurse and the others: workplace and personal characteristics impact preference of nursing tasks

Journal of nursing management, 2014-11, Vol.22 (8), p.1054-1064

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunosenescence and Cytomegalovirus: where do we stand after a decade?

Immunity & ageing, 2010-09, Vol.7 (1), p.13-13, Article 13

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study

Vaccine: X, 2022-08, Vol.11, p.100189-100189, Article 100189

2022

Link zum Volltext

Verfügbarkeit prüfen

Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses

Kidney international, 2010-11, Vol.78 (9), p.934-940

2010

Link zum Volltext

Verfügbarkeit prüfen

Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy

Oncoimmunology, 2016-12, Vol.5 (12), p.e1249560-e1249560

2016

Link zum Volltext

Verfügbarkeit prüfen

Clonal evolution of CD8+ T cell responses against latent viruses: relationship among phenotype, localization, and function

Journal of virology, 2015-01, Vol.89 (1), p.568-580

2015

Link zum Volltext

Verfügbarkeit prüfen

How to approximate users’ values while preserving privacy: experiences with using attitudes towards work tasks as proxies for personal value elicitation

Ethics and information technology, 2013-03, Vol.15 (1), p.45-61

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

The Lancet (British edition), 2017-09, Vol.390 (10101), p.1511-1520

2017

Link zum Volltext

Verfügbarkeit prüfen

Self-adjuvanted RNActive® vaccine induces local immune responses at the injection site leading to potent adaptive immunity in mice and humans

Journal for immunotherapy of cancer, 2014-11, Vol.2 (Suppl 3), p.P172-P172, Article P172

2014

Link zum Volltext

Verfügbarkeit prüfen

A far-view intensive care unit monitoring display enables faster triage

Dimensions of critical care nursing, 2011-07, Vol.30 (4), p.206

2011

Link zum Volltext

Verfügbarkeit prüfen

Alloantigen-induced regulatory CD8+ CD103+ T cells

Human immunology, 2008-11, Vol.69 (11), p.737-744

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 617

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(535)
Mit Volltextzugriff
(555)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(574)
Japanisch
(62)
Deutsch
(47)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Evaluation of the effect of information integration in displays for ICU nurses on situation awareness and task completion time: A prospective randomized controlled study

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial

A novel, disruptive vaccination technology: Self-adjuvanted RNActive® vaccines

A large multicentre, randomized, double‐blind, cross‐over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US‐ and EU‐reference biologics

Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people

Intensive care unit nurses' information needs and recommendations for integrated displays to improve nurses' situation awareness

Analysis of stem-cell-like properties of human CD161++IL-18Rα+ memory CD8+ T cells

Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity

A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant

Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas

The perfectly motivated nurse and the others: workplace and personal characteristics impact preference of nursing tasks

Immunosenescence and Cytomegalovirus: where do we stand after a decade?

Corrigendum to “Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study” [Vaccine: X 11 (2022) 100189]

Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study

Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses

Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy

Clonal evolution of CD8+ T cell responses against latent viruses: relationship among phenotype, localization, and function

How to approximate users’ values while preserving privacy: experiences with using attitudes towards work tasks as proxies for personal value elicitation

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

Self-adjuvanted RNActive® vaccine induces local immune responses at the injection site leading to potent adaptive immunity in mice and humans

A far-view intensive care unit monitoring display enables faster triage

Alloantigen-induced regulatory CD8+ CD103+ T cells

Suchergebnisse filtern